Thomas R. Nirschl

Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen

Andrew B. Sharabi, Christopher J. Nirschl, Christina M. Kochel et al. · Cancer Immunology Research · 2014 · 647 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy

Ariel E. Marciscano, Ali Ghasemzadeh, Thomas R. Nirschl et al. · Clinical Cancer Research · 2018 · 325 citations · Full text

Medicine, Immunology, Oncology +17

Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment

Yuki Muroyama, Thomas R. Nirschl, Christina M. Kochel et al. · Cancer Immunology Research · 2017 · 208 citations · Full text

Medicine, Immunology, Oncology +17

Paucity of PD-L1 expression in prostate cancer: innate and adaptive immune resistance

Allison Martin, Thomas R. Nirschl, Christopher J. Nirschl et al. · Prostate Cancer and Prostatic Diseases · 2015 · 186 citations

Life Sciences, Immunology, Oncology +16

Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer

Karim Boudadi, Daniel L. Suzman, Valsamo Anagnostou et al. · Oncotarget · 2018 · 157 citations · Full text

Medicine, Oncology, Pharmacotherapy +17